In a historic medical first, an infant has undergone the world’s first personalized gene-editing treatment using CRISPR technology. This groundbreaking procedure was executed by a team of doctors from US institutions, who successfully corrected a genetic mutation responsible for a rare and life-threatening disorder. The baby, born with a severe condition, is now thriving following the customized therapy, which was developed in an unprecedented timeframe of just six months. Experts believe this pioneering treatment could pave the way for future therapies tailored to individual patients with unique genetic disorders, potentially transforming the landscape of genetic medicine.